cultured cells), it is possible to label proteins during translation through incorporation of "heavy" amino acids. Proteomes from cells grown in the presence of different labels, exposed to different experimental manipulations, can be compared side by side with the analyzed peptides showing up as distinct peaks in the mass spectrometer ( Figure 1 ). Rajewsky and coworkers used a particularly ingenious implementation of SILAC termed pulsed SILAC (pSILAC) (Selbach et al., 2008) . In this approach, labeling is restricted to newly synthesized proteins, permitting the determination of protein synthesis rates and providing high sensitivity. In contrast, conventional SILAC quantifies changes in protein concentrations, which respond to additional factors including intrinsic protein half-lives and regulated turnover. However, assuming that the total concentration of a protein rather than its current rate of synthesis determines biological outcomes, changes identified by SILAC might be equally relevant, such that SILAC and pSILAC should be viewed as complementary approaches. Both groups initially focused on human HeLa cells, which they transfected with individual mature miRNAs. Whereas the Bartel group examined the effects on nuclear proteins, Rajewsky and colleagues looked at total protein composition. Examining 2000 to 5000 distinct proteins each, both approaches were able to expand on an earlier effort (Vinther et al., 2006) Two recent studies published in Nature (Baek et al. 2008; Selbach et al., 2008) analyze changes in the proteome in response to individual microRNAs (miRNAs). This approach is a powerful means to identify miRNA targets and to quantify the contribution of translational repression to posttranscriptional gene silencing by miRNAs. SILAC (stable-isotope labeling by amino acids in cultured cells) is a method for labeling proteins during translation through incorporation of "heavy" amino acids. In pulsed SILAC (pSILAC), cells are experimentally manipulated while growing in "light" (L) SILAC medium. Subsequently, treated and control cells are transferred to distinctly labeled SILAC media. After one or a few doublings, cells are harvested and combined before protein is extracted. Protein present before treatment will show up as an L peak in the mass spectrograph and can be ignored. The effect of the treatment on protein production rates can be calculated as the ratio of signal at the "medium-heavy" (M) and "heavy" (H) peaks. In regular SILAC, cells are pregrown for several doublings in M or H medium (or, more typically, L or H medium) before being exposed to experimental treatment. There will thus only be two peaks of protein, each reflecting a mixture of newly synthesized protein and preexisting stable protein.
observed, with hundreds of proteins changing detectably in a typical experiment, many of them quite significantly. Analysis of changes in mRNA levels indicated that repression of protein is frequently mirrored by decreased transcript levels (Selbach et al., 2008; Baek et al., 2008) , suggesting that most targets can be identified without a need for sophisticated proteomics approaches. However, pSILAC in particular identified a substantial number of targets where translational repression is the major component of mRNA silencing (Selbach et al., 2008) . One particularly intriguing example involves the miRNA-processing enzyme Dicer, whose mRNA levels change by 30% when the miRNA let-7b is blocked, whereas its translation rate changes more than 4-fold. On the basis of the moderate change in Dicer mRNA levels, few people might have been inclined to investigate Dicer as a let-7b target.
The finding that mRNA degradation and protein repression typically occur together brings up the possibility that mRNA degradation is a major determinant of miRNA repression. There are two caveats to this interpretation. First, both groups used microarray profiling strategies that depend on labeling of polyadenylated mRNA to assess mRNA levels. Because deadenylation can affect not only mRNA stability but also translation, this approach might underestimate the contribution of translational repression. Second, it remains possible that translational repression might precede degradation. Consistent with this notion, mRNA levels were found to decrease with prolonged miRNA exposure (Selbach et al., 2008) . Moreover, whereas target degradation appeared to correlate well with changes in protein concentrations (Baek et al., 2008) , miRNAs had much more pronounced effects on rates of protein synthesis measured by pSILAC (Selbach et al., 2008) . It will be informative to learn more about the targets that are regulated preferentially at the translational level and to understand their relevance to the cellular function of miRNAs. Do these targets need to be regulated within particularly tight boundaries? Can their repression be reversed? What is causing their stability: is there a difference in the architecture of their target sites, or are there other factors in the cells that prevent their degradation?
Ectopic expression or overexpression of miRNAs might not produce the same effects as endogenous miRNAs. Both groups performed additional experiments to address this possibility. The Rajewsky group examined the effect of blocking an abundant endogenous miRNA, let-7b, in HeLa cells and found that many of the genes that had been downregulated when overexpressing let-7b were now upregulated (Selbach et al., 2008) . Although overexpression of let-7 would thus appear to affect expression of many of the same genes that are affected when blocking this miRNA, the extent of deregulation upon let-7 overexpression was higher than that seen with inhibition of let-7.
The Bartel group circumvented the problem of transfection, and the associated cellular stress, by examining nuclear and cytoplasmic proteins from mutant mouse neutrophils lacking expression of miR-223 and also found that changes in protein expression were comparable to the patterns seen in transfection experiments (Baek et al., 2008) . This experiment is important for another reason: in the overexpression experiments, most miRNAs were transfected into the cells as perfectly complementary, double-stranded miRNA mimics. In flies and worms, miRNAs derived from such perfectly complementary precursors are sorted into different effector complexes than are the miRNAs derived from the typical miRNA precursors containing loops and bulges (Bellare and Sontheimer, 2007) . Although it is not clear that similar mechanisms operate in humans, the mode of exogenous miRNA provision might affect the mechanism of action used by miRNAs to silence their targets.
With one miRNA causing expression changes in hundreds of proteins, it remains an open question how many of these changes are important to the function of the individual miRNA. Many of these effects might be neutral, with altered levels not compromising the cellular function of the affected protein. For the others, it will be interesting to learn whether the proteins that are more strongly regulated have greater relevance to miRNA function, consistent with a switch-like model of miRNA activity, or whether fine-tuning, possibly affecting many targets by a modest extent, is more frequently the important scenario (Hobert, 2007) . However, when interpreting the extent to which protein expression changes, it is worthwhile to keep in mind that miRNA activity itself can be regulated. Effects seen in one cell line might be quite different from those found in another in which other potential target genes and also other modulators of miRNA activity may be expressed (Mishima et al., 2006; Kedde et al., 2007; Bhattacharyya et al., 2006) . It will thus be particularly illuminating to study the effects of the same miRNA in different cells.
In this context, it is somewhat disappointing that neither report comments on the fraction and identity of previously validated targets that have been recovered with the new approaches-despite the fact that there is an abundance of such targets, certainly for miR-1 and let-7. This would be particularly relevant for miR-1-whose effect on HeLa cells was examined in both the new (Baek et al., 2008; Selbach et al., 2008) and the earlier reports (Vinther et al., 2006) -so that comparison of the results could provide some idea of the robustness of the methods. Ultimately, it would be most interesting to perform comparable SILAC experiments in additional systems, particularly in whole animals (Krüger et al., 2008) .
Beyond information on specific targets, identification of this large cohort of genes regulated by miRNAs might tell us more about sequence features that define miRNA targets and thus improve computational target prediction. On this issue, conclusions diverge. With pSILAC, the best algorithms reach a false-positive rate below 40% (Selbach et al., 2008) . It is here that the capability of pSILAC to look at translation rates, subject to fewer indirect effects than are protein concentrations, might reap its greatest rewards. In contrast, when SILAC was used, even the most successful algorithms still had a falsepositive rate greater than two out of three (Baek et al., 2008) . Conversely, a substantial fraction of proteins that did change were not predicted as targets. Thus, both papers provide evidence that target predictions developed from microarray analyses largely apply to targets regulated by translational repression, but additional improvements are needed, possibly resulting in the identification of new sequence and structure parameters for this target class.
The two reports (Baek et al., 2008; Selbach et al., 2008) have provided a wealth of data that will keep both experimental and computational biologists busy for some time to come. The wider application of these powerful new approaches to different experimental systems will help to address many of the questions that we have raised here.
Mammals have developed elaborate mechanisms to prevent disease and injury and to initiate healing responses should those prevention mechanisms fail. A good example of a disease-prevention mechanism is cellular senescence, a state in which cell division is permanently arrested (reviewed in Collado et al., 2007) . This phenomenon was originally discovered in cultured primary cells that stop proliferating after a finite number of divisions (replicative senescence). We now know that replicative senescence is due, at least in part, to erosion of telomeres, which occurs at each cell division. Senescent cells have a distinct phenotype that includes characteristic alterations in morphology, gene expression patterns, and chromatin structure. Specific genes are known to be required for senescence induction, thus revealing the existence of a defined genetic program. But why would cells develop a mechanism to permanently halt proliferation? Findings in experimental mouse cancer models and with human tumor samples hinted at the answer: precancerous tissues are composed of senescent cells (reviewed in Campisi, 2005; Sharpless and DePinho, 2005) . These observations led to the notion that induction of cellular senescence provides an intrinsic barrier to cancer development by preventing the proliferation of cells that are damaged or at risk for neoplastic transformation. In this issue, Krizhanovsky et al. (2008) add a new dimension to the cellular senescence story by demonstrating that senescence is also required in the normal response to injury in the liver.
In their original studies of the physiological response to liver damage in a mouse model, Krizhanovsky and colleagues, rather surprisingly, observed senescent cells in the liver. In their liver injury model, mice are treated with the chemical carbon tetrachloride to induce fibrosis, the primary response of the liver to injury. Fibrosis is a wound healing process characterized by the deposition of extracellular matrix components including collagens, proteoglycans, and fibronectins, which help to encapsulate the injury site (reviewed in Friedman, 2008) . Liver fibrosis is a precursor to cirrhosis, a significant health problem caused by diverse liver-damaging agents such as excessive alcohol, viral hepatitis, and toxins. Hepatic stellate cells (HSCs) are the primary modulators of liver fibrosis and are activated following damage to hepatocytes, the predominant cell type in liver tissue. Activated HSCs are characterized by increased proliferation and motility and, most importantly, by increased synthesis of extracellular matrix components. Krizhanovsky et al.
